95 related articles for article (PubMed ID: 35927466)
1. Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy.
Yan S; Shi YJ; Liu C; Li XT; Zhao B; Wei YY; Shen L; Lu ZH; Sun YS
Eur Radiol; 2023 Jan; 33(1):380-390. PubMed ID: 35927466
[TBL] [Abstract][Full Text] [Related]
2. Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
Lian HM; Wu JL; Liufu WJ; Yu TT; Niu SQ; Bao Y; Peng F
Cancer Immunol Immunother; 2024 Feb; 73(3):55. PubMed ID: 38366287
[TBL] [Abstract][Full Text] [Related]
3. Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders.
Greally M; Chou JF; Molena D; Rusch VW; Bains MS; Park BJ; Wu AJ; Goodman KA; Kelsen DP; Janjigian YY; Ilson DH; Ku GY
J Thorac Oncol; 2019 Mar; 14(3):540-546. PubMed ID: 30391577
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [
Zhao L; Pang Y; Chen S; Chen J; Li Y; Yu Y; Huang C; Sun L; Wu H; Chen H; Lin Q
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):593-601. PubMed ID: 36222855
[TBL] [Abstract][Full Text] [Related]
5. Effects of intensity-modulated radiotherapy combined with chemotherapy and prognostic factors in patients with locally advanced oesophageal cancer.
Ou Y; Li H; Yang D; Suo L
Adv Med Sci; 2024 Mar; 69(1):125-131. PubMed ID: 38438081
[TBL] [Abstract][Full Text] [Related]
6. Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial.
Chen M; Huang Y; Zhang S; Zheng Y; Zeng T; Chen C; Zheng B
BMJ Open; 2024 Feb; 14(2):e075421. PubMed ID: 38418234
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Cox S; Hurt C; Grenader T; Mukherjee S; Bridgewater J; Crosby T
Radiother Oncol; 2017 Oct; 125(1):154-159. PubMed ID: 28893415
[TBL] [Abstract][Full Text] [Related]
8. Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study.
Zheng H; Zhang H; Zhu Y; Wei X; Liu S; Ren W
BMC Med Imaging; 2024 Jan; 24(1):18. PubMed ID: 38216885
[TBL] [Abstract][Full Text] [Related]
9. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation versus oesophagectomy for locally advanced oesophageal cancer in Chinese patients: study protocol for a randomised controlled trial.
Jia R; Yin W; Li S; Li R; Yang J; Shan T; Zhou D; Wang W; Wan L; Zhou F; Gao S
Trials; 2019 Apr; 20(1):206. PubMed ID: 30971301
[TBL] [Abstract][Full Text] [Related]
11. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
[TBL] [Abstract][Full Text] [Related]
12. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
13. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
[TBL] [Abstract][Full Text] [Related]
14. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
[TBL] [Abstract][Full Text] [Related]
15. Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion.
Huang Y; Huang X; Wang A; Chen Q; Chen G; Ye J; Wang Y; Qin Z; Xu K
BMC Med Inform Decis Mak; 2023 Oct; 23(1):237. PubMed ID: 37872517
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma.
Zhang C; Guo Z; Jing Z
Int J Nanomedicine; 2024; 19():1351-1362. PubMed ID: 38352821
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning.
Kawahara D; Murakami Y; Tani S; Nagata Y
Br J Radiol; 2022 Jul; 95(1135):20210934. PubMed ID: 35451338
[TBL] [Abstract][Full Text] [Related]
18. The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours.
Resteghini C; Castelnuovo P; Nicolai P; Orlandi E; Bossi P; Vischioni B; Schreiber A; Gambazza S; Iacovelli NA; Battaglia P; Guzzo M; Turri-Zanoni M; Mattavelli D; Facchinetti N; Calareso G; Ravanelli M; Facco C; Tartaro T; Licitra L
Eur J Cancer; 2023 Jul; 187():185-194. PubMed ID: 37164774
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data.
Li ZM; Liu W; Chen XL; Wu WZ; Xu XE; Chu MY; Yu SX; Li EM; Huang HC; Xu LY
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102318. PubMed ID: 38471582
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in chemoradiotherapy for oesophageal squamous cell carcinoma.
Oshima K; Tsushima T; Ito Y; Kato K
Jpn J Clin Oncol; 2024 Apr; 54(4):395-402. PubMed ID: 38342589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
